Nature Foods for the Treatment of Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Sun, Mengxia [1 ]
Ye, Hua [1 ,2 ]
机构
[1] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo, Peoples R China
[2] Ningbo Univ, Affiliated Lihuili Hosp, Ningbo 315040, Peoples R China
关键词
mechanism; NAFLD; nature food; therapy; DIET-INDUCED OBESITY; LYCIUM-BARBARUM; HEPATIC STEATOSIS; CHLOROGENIC ACID; OXIDATIVE STRESS; GENE-EXPRESSION; LIPID PROFILE; DOUBLE-BLIND; HEPG2; CELLS; PPAR-GAMMA;
D O I
10.1089/jmf.2022.K.0052
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide. The etiology of NAFLD is highly heterogeneous, which occurs and develops under the joint action of metabolism, inflammation, genetics, environment, and gut microbiota. At present, the principal therapeutic modalities targeting NAFLD are lifestyle interventions such as weight loss through diet and exercise. At present, there is no established therapy for the treatment of NAFLD, and many therapies are associated with a variety of side effects. A great number of in vitro and in vivo experiments have indicated that there are many natural foods that have therapeutic potential for NAFLD. This review summarizes the natural foods and their mechanisms that were found in recent years, furthermore, provides further information relevant to the treatment of NAFLD.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 50 条
  • [31] Insecticide Exposure and Development of Nonalcoholic Fatty Liver Disease
    Yang, Jason S.
    Park, Yeonhwa
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2018, 66 (39) : 10132 - 10138
  • [32] Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet
    Mokhtari, Zeinab
    Gibson, Deanna L.
    Hekmatdoost, Azita
    ADVANCES IN NUTRITION, 2017, 8 (02) : 240 - 252
  • [33] Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Beaton, Melanie D.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 26 (06) : 353 - 357
  • [34] Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
    Maseroli, E.
    Comeglio, P.
    Corno, C.
    Cellai, I
    Filippi, S.
    Mello, T.
    Galli, A.
    Rapizzi, E.
    Presenti, L.
    Truglia, M. C.
    Lotti, F.
    Facchiano, E.
    Beltrame, B.
    Lucchese, M.
    Saad, F.
    Rastrelli, G.
    Maggi, M.
    Vignozzi, L.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (04) : 819 - 842
  • [35] Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)
    Fan, Jian Gao
    Wei, Lai
    Zhuang, Hui
    JOURNAL OF DIGESTIVE DISEASES, 2019, 20 (04) : 163 - 173
  • [36] Essential Oils for the Treatment and Management of Nonalcoholic Fatty Liver Disease (NAFLD)
    Kim, Taehwa
    Mijan, Mohammad Al
    Lee, Jeonga
    Yun, Jungmi
    Chung, Jae Heun
    Son, Soo Min
    Kwon, Ryuk Jun
    NATURAL PRODUCT COMMUNICATIONS, 2024, 19 (04)
  • [37] Evaluation of Statin Treatment for Nonalcoholic Fatty Liver Disease
    Newsome, Jonathan S.
    JOURNAL OF PHARMACY TECHNOLOGY, 2016, 32 (04) : 169 - 173
  • [38] Advances in the Understanding and Treatment of Nonalcoholic Fatty Liver Disease
    Stephen A. Harrison
    Adrian M. Di Bisceglie
    Drugs, 2003, 63 : 2379 - 2394
  • [39] Review of Treatment Options for Nonalcoholic Fatty Liver Disease
    Corrado, Richele L.
    Torres, Dawn M.
    Harrison, Stephen A.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 55 - +
  • [40] Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease
    Makri, Evangelia
    Goulas, Antonis
    Polyzos, Stergios A.
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (01) : 25 - 37